We recently published a list of 10 Worst Blue Chip Stocks to Buy. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against other worst blue chip stocks to buy. As per Niamh Brodie-Machura, Co-Chief Investment …
BMO Capital analyst Jeffrey Silber raised the firm’s price target on First Advantage (FA) to $21 from $16 and keeps an Outperform rating on the shares. The company’s Q1 results beat expectations, mainly driver by better-than-expected margins, while its volumes held up well and …
Release Date: May 09, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Suzano SA (NYSE:SUZ) reported sales volume growth year over year, particularly in its Brazilian and American operations. The company successfully implemented …
We recently published a list of 10 Worst Blue Chip Stocks to Buy. In this article, we are going to take a look at where NIKE, Inc. (NYSE:NKE) stands against other worst blue chip stocks to buy. As per Niamh Brodie-Machura, Co-Chief Investment Officer …
Porsche's (P911.DE) first electrified 911 is here, but it comes at a time of great concern for the iconic German brand. The 911 Carrera GTS T-Hybrid uses an innovative hybrid system that's much different from the hybrid approach used for the brand's non-sports cars, …
We recently published a list of 10 Worst Blue Chip Stocks to Buy. In this article, we are going to take a look at where KKR & Co. Inc. (NYSE:KKR) stands against other worst blue chip stocks to buy. As per Niamh Brodie-Machura, Co-Chief …
AngloGold Ashanti (NYSE:AU) First Quarter 2025 Results Key Financial Results Revenue: US$1.96b (up 54% from 1Q 2024). Net income: US$443.0m (up 185% from 1Q 2024). Profit margin: 23% (up from 12% in 1Q 2024). The increase in margin was driven by higher revenue. EPS: …
Stifel lowered the firm’s price target on Hub Group (HUBG) to $45 from $52 and keeps a Buy rating on the shares. Intermodal pricing is under broad pressure as squishy demand has begotten a softer contracting environment with shippers opportunistically pulling bids forward, but …
Telsey Advisory lowered the firm’s price target on Warby Parker (WRBY) to $22 from $30 and keeps an Outperform rating on the shares. The company reported a “solid” Q1, with adjusted EBITDA beating expectations, the analyst tells investors. The firm is moderating its price …
Stifel analyst Daniel Arias lowered the firm’s price target on Illumina (ILMN) to $135 from $160 and keeps a Buy rating on the shares. Illumina posted a “nice” Q1 beat and then reduced the FY25 guidance, as expected, the analyst tells investors. The cut …